30 closest matches · ranked by relevance
Liver Carcinoma
Primary: Percentage of Participants Surviving at One and Four Years After Liver Transplant — 85; 77 percentage of participants
Hepatitis C · Liver Transplantation
Primary: Number of Participants Sustained Virological Response (SVR) Following Treatment of Hepatitis C Virus (HCV) Infection With Peg-IFN and Ribavirin in Liver Transplanted…
Hepatitis C · Hepatitis C, Chronic · Nonimmune Nonviral Causes of Liver Failure
Primary: Number of Participants With Clinical Complications Usually Attributed to Immunosuppression — 12; 4 participants
Heart Failure
Primary: Sustained Virologic Response After Treatment — 24 Participants
Hepatitis C · Cirrhosis
Primary: HCV RNA Result — 924,082; 3,731,749 IU/ml
Liver Transplant · Hepatitis C
Primary: Adverse Events Due to Sofosbuvir/Velpatasvir (Epclusa) — 0; 0 Participants
Liver Transplant · Liver Transplantation
Primary: Proportion of Participants Successfully Withdrawn From Immunosuppression — 0.60 Proportion of participants
Cirrhosis of the Liver
Primary: Perceived HRQoL Score. Overall Qualty of Life Index Tool Was Utilized. — 20.19 scores on a scale
Liver Transplant Recipient · Living Donor (of the Respective Liver Transplant Recipient)
Primary: Number of Participants Who Experienced Grade 3 or Higher Adverse Events (AEs) Deemed Attributable to darTreg Infusion — 0 Participants
End Stage Renal Disease · Hepatitis C
Primary: Viral Response at Week 12 — 10 Participants
Lung Diseases
Primary: Subject Sustained Virologic Response (SVR-12) at 12-weeks Post-treatment — 10 Participants
End Stage Liver Disease · Hepatitis C
Primary: Freedom From Acute Rejection or HCV Recurrence or Treatment Failure — 69; 70; 133 participants
Liver Failure
Primary: The Incidence of Acute Kidney Injury (AKI) as Assessed by Change in Serum Creatinine From Baseline to 30 Days Post-transplant — .01; .06 mg/dL
Liver Transplant
Primary: Physical Activity Measured by the International Physical Activity Questionnaire (IPAQ) — 407; 1711 MET
Reperfusion Injury
Primary: Peak Aspartate Aminotransferase Within First 72h Post Transplant — 1262.9; 1451.2 U/L
End Stage Renal Disease · Hepatitis C
Primary: Viral Response as Assessed by Number of Participants With Undetectable Hepatitis C RNA — 10 Participants
Liver Transplantation · Surgical Site Infection
Primary: Number of Subjects With Development of Surgical Site Infections — 9; 13 Participants
Liver Transplant · Liver Steatosis · Liver Disease
Primary: Controlled Attenuation Parameter (CAP) - Accuracy — 220 dB/m
Living Donor Liver Transplantation
Primary: Proportion of Safety Events — 1 Participants
Hepatitis C
Primary: Patients Who Are Negative for Hepatitis C Virus (HCV) RNA at 3 Months Post-transplant: Intent-to-Treat Analysis (ITT) — 0; 5; 6 participants — p=0.0477
Evidence of Liver Transplantation · Hyperglycemia · Rejection
Primary: Rejection of Liver Transplant — 17; 20 participants — p=0.709
Hepatitis C
Primary: Treatment Efficacy — 88; 75 % of participants
Hepatitis C
Primary: Number of Incidences of Viremia After Receiving a Lung Transplant From a Donor Who Tests Positive for Hepatitis C — 16 incidences
Liver Transplantation
Primary: Number of Participants With Composite Efficacy Failure of Treated Biopsy Proven Acute Rejection, Graft Loss or Death in Everolimus With Reduced Tacrolimus Group Compared…
Liver Cirrhosis · Hepatocellular Carcinoma · Evidence of Liver Transplantation
Primary: Side Effect of Cadaveric Donor Liver NK Cell Infusion — 0; 0 participants
Liver Transplant
Primary: Infection Rates — 27; 26; 11; 7 Participants — p=0.841
Hemophilia · Hemophilia B
Primary: Number of Participants Requiring Immunosuppressive Therapy After Liver Transplantation — 7; 6; 4; 3 Participants
Kidney Transplant · Hepatitis C · HCV
Primary: Proportion of Patients With Undetectable Hepatitis C Virus (HCV) Polymerase Chain Reaction (PCR) at 12 Weeks After Completion of HCV Treatment — 28 Participants
Hepatitis C · Hepatocellular Carcinoma
Primary: Percentage of Participants With Posttransplant Virologic Response (pTVR) at Posttransplant Week 12 — 75.0; 69.8 percentage of participants
Ischemia Reperfusion Injury
Primary: Lowest 5 Minutes Post-reperfusion Mean Arterial Blood Pressure — 66.03; 57.75 mmHg